Showing results (61-70 of 81) with videos related to

Sort By:
Pageof 9
British Journal of Cancer|June 27, 2002
Oxaliplatin plus raltitrexed and leucovorin-modulated 5-fluorouracil i.v. bolus: a salvage regimen for colorectal cancer patientsP Comella, R Casaretti, E Crucitta, et al.
Lung Cancer (Amsterdam, Netherlands)|December 18, 2001
Gemcitabine plus vinorelbine yields better survival outcome than vinorelbine alone in elderly patients with advanced non-small cell lung cancer. A Southern Italy Cooperative Oncology Group (SICOG) phase III trialG Frasci, V Lorusso, N Panza, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 4, 1999
Cisplatin-topotecan-paclitaxel weekly administration with G-CSF support for ovarian and small-cell lung cancer patients: a dose-finding studyG Frasci, N Panza, P Comella, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 16, 2000
Weekly docetaxel plus gemcitabine or vinorelbine in refractory advanced breast cancer patients: a parallel dose-finding study. Southern Italy Cooperative Oncology Group (SICOG)G Frasci, P Comella, G D'Aiuto, et al.
British Journal of Cancer|December 1, 1996
Cisplatin/carboplatin + etoposide + vinorelbine in advanced non-small-cell lung cancer: a multicentre randomised trial. Gruppo Oncologico CampanoP Comella, G Frasci, G De Cataldis, et al.
Oncology Reports|January 12, 2005
Randomised, open-label, phase II trial of paclitaxel, gemcitabine and cisplatin versus gemcitabine and cisplatin as first-line chemotherapy in advanced transitional cell carcinoma of the urotheliumVito Lorusso, Enrico Crucitta, Nicola Silvestris, et al.
European Journal of Cancer (Oxford, England : 1990)|January 20, 1999
Carboplatin-oral etoposide personalized dosing in elderly non-small cell lung cancer patients. Gruppo Oncologico Cooperativo Sud-ItaliaG Frasci, P Comella, N Panza, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 13, 2000
Phase I and pharmacokinetic study of tomudex combined with 5-fluorouracil plus levofolinic acid in advanced head and neck cancer and colorectal cancerF Caponigro, A Avallone, H McLeod, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 19, 2002
Addition of either irinotecan or methotrexate to bolus 5-fluorouracil and high-dose folinic acid every 2 weeks in advanced colorectal carcinoma: a randomised study by the Southern Italy Cooperative Oncology GroupP Comella, E Crucitta, F De Vita, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 13, 2000
Gemcitabine plus vinorelbine versus vinorelbine alone in elderly patients with advanced non-small-cell lung cancerG Frasci, V Lorusso, N Panza, et al.
Pageof 9